FDA Approves "Revolutionary" Cancer-Killer Gene Therapy
Nick Tate : Oct 20, 2017
"Today marks another milestone in the development of a whole new scientific paradigm for the treatment of serious diseases. In just several decades, gene therapy has gone from being a promising concept to a practical solution to deadly and largely untreatable forms of cancer." — FDA Commissioner Dr. Scott Gottlieb
(Washington, DC) — [Newsmax Health] Federal regulators have approved a game-changing immunotherapy cancer drug to treat patients with certain types of lymphoma that uses a patient's own cells to boost the immune system to fight the disease… (Photo Credit: Kite Pharma)
Yescarta – known as CAR-T cell therapy – has been shown to be effective in treating adult patients with certain types of large B-cell lymphoma.
Click here to continue reading.